PhRMA Kicks Off Year Attacking China, Wrapping Agenda In American Flag

 
• By Sarah Karlin-Smith

US pharma leadership is painting its mission, particularly its goal to end Medicare price controls, as patriotic and essential to America’s global dominance over China, a move that seems designed to align with President Trump’s priorities.

American flag
PhRMA warned that the US risks losing ground to China in the biomedical innovation race if government policies like Medicare price negotiation are not changed. (Shutterstock)

More from Pricing Debate

More from R&D